Characterization of Interfraction Changes and Their Dosimetric Effects for Prostate Radiotherapy Using Daily Kvct

G. Chen,C. Peng,E. Ahunbay,C. Lawton,X. Li
DOI: https://doi.org/10.1016/j.ijrobp.2008.06.164
2008-01-01
Abstract:The interfraction variations during prostate radiotherapy can be significant due to setup errors, organ motion and deformation. Simple (e.g., repositioning based on rigid-body/ soft-tissue registration), intermediate (e.g., aperture morphing) and complex (e.g., full-scope re-optimization based on the CT of the day) schemes are proposed/used to correct these variations. The purpose of this work is to quantitatively characterize the interfraction variations and their dosimetric effects and to determine the frequencies of different adaptive correction strategies. Daily kVCT images for 20 prostate patients treated with daily CT-guided repositioning using a linac and CT-on-Rail combo (CTVision, Siemens) were analyzed. The prostate, rectum and bladder were delineated on each daily CT dataset. The daily organ contours were compared to the planning contours after bony anatomy registration. Several quantities, including Dice's coefficient (DC), maximum overlapping rate (MOR), were calculated for each structure and were used to characterize the prostate motion and deformation. The delivered dose of the day was reconstructed by applying original beam setting to the CT of the day considering the repositioning shifts. Based on the magnitude of the interfraction variations and their dosimetric effects, the frequency for various adaptive correction schemes was suggested. The mean prostate DC is 69.7 ± 13.8% (1σ). In 76% of all cases, DC is lower than 80%. In 57% of all cases, MOR is greater than 85%; 39% is between 70% and 85%; only 4% is below 70%. The reconstructed delivered dose distributions based on daily CT datasets are generally inferior to the planned dose distribution in term of target coverage and/or organs-at-risk sparing. For example, for approximately 5% of the treatment fractions, V100 of the prostate were dramatically lower than those for the original plans (as low as 20%). The magnitudes of the interfraction variations and their dosimetric effects indicate that, on average, the current standard repositioning based on prostate alignment may be adequate to correct for the interfraction variations in 60-80% of the treatment fractions, while aperture morphing may be used in 20-35% of the fractions. The full-scope re-planning may be required for 5-10% of fractions. Criteria in terms of several daily anatomic variation parameters (e.g., DC, MOR) for selecting an adaptive scheme were suggested. The different magnitude of interfraction changes in prostate radiotherapy demands different adaptive correction schemes, which can be selected based on anatomic quantities such as COM, DC and MOR as determined from the CT of the day.
What problem does this paper attempt to address?